Acesso livre
Acesso livre

Arquivos do dia: Agosto 2, 2021

O estudo por trás da nova diretriz do CDC sobre uso de máscara mostra que pessoas vacinadas podem disseminar a variante Delta.

2 Ago, 2021 | 19:20h

Relatório do CDC: Outbreak of SARS-CoV-2 Infections, Including COVID-19 Vaccine Breakthrough Infections, Associated with Large Public Gatherings — Barnstable County, Massachusetts, July 2021 – Centers for Disease Control and Prevention

Comentários:

The Study Behind CDC’s Mask Guidance Found Vaccinated People Can Spread Delta Variant – NPR

What Delta has changed in the Covid pandemic — and what it hasn’t – STAT

 

Comentário no Twitter (fio – clique para saber mais)

 

Recomendações da ACOG e da SMFM para a vacinação contra COVID-19 em gestantes – “ACOG encoraja seus membros a recomendar enfaticamente a vacinação para suas pacientes.”

2 Ago, 2021 | 19:18h

ACOG and SMFM Recommend COVID-19 Vaccination for Pregnant Individuals – American College of Obstetricians and Gynecologists (ACOG) and the Society for Maternal-Fetal Medicine (SMFM)

Leituras adicionais:

Practice Advisory: COVID-19 Vaccination Considerations for Obstetric-Gynecologic Care

COVID-19 Vaccines and Pregnancy: Conversation Guide for Clinicians

Comentários:

Obstetrician groups recommend COVID vaccine during pregnancy – Associated Press

Statements By Obstetrics Societies Strongly Advise Covid-19 Vaccinations For Pregnant Women – Forbes

 

Comentário no Twitter

 

Opinião | Gestantes devem se vacinar contra COVID? As evidências mostram que é seguro e eficaz.

2 Ago, 2021 | 19:16h

Should pregnant women have a COVID vaccine? The evidence says it’s safe and effective – The Conversation

Diretriz | Abordagem clínica de adultos com COVID-19 fora da UTI.

2 Ago, 2021 | 19:13h

Clinical Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP) – Infectious Diseases and Therapy

O que todo intensivista deveria saber sobre o tocilizumabe.

2 Ago, 2021 | 19:11h

What every intensivist should know about Tocilizumab – Critical Care

Conteúdos relacionados:

Tocilizumab in COVID-19 therapy: who benefits, and how?

A living WHO guideline on drugs for covid-19 – interleukin-6 receptor blockers are now recommended for patients with severe or critical covid-19.

M-A: Association Between Administration of IL-6 Antagonists and Mortality Among Patients Hospitalized for COVID-19 – “The 4% absolute risk reduction in mortality from 25% to 21% with IL-6 inhibition added to glucocorticoids may not translate to patients with a lower baseline mortality risk and likely do not justify the additional expense and risk for toxicities for patients hospitalized with modest oxygen requirements and a stable clinical course (from editorial)”.

RECOVERY trial: In hospitalized COVID-19 patients with hypoxia and systemic inflammation (C-reactive protein ≥75 mg/L), tocilizumab improved survival and other clinical outcomes

Secondary analysis of RCT finds Tocilizumab was beneficial to patients hospitalized with Covid-19 if CRP levels were greater than 15.0 mg/dL, but not if CRP levels were 15.0 mg/dL or less.

M-A: Tocilizumab in COVID-19 – “For hospitalized COVID-19 patients, there is some evidence that tocilizumab use may be associated with a short-term mortality benefit, but further high-quality data are required”.

Efeitos pós-virais da COVID-19 no sistema olfatório e suas implicações.

2 Ago, 2021 | 19:09h

Post-viral effects of COVID-19 in the olfactory system and their implications – The Lancet Neurology

Conteúdo relacionado:

Study finds 96.1% of patients objectively recovered from anosmia 1 year after COVID-19 diagnosis.

Eight out of ten people hospitalized with COVID-19 develop neurological problems – the most common self-reported symptoms included headache (37%) and anosmia or ageusia (26%).

Loss of smell in mild Covid-19 cases occurs 86% of the time, study says

Management of anosmia and loss of smell in the era of Covid-19

Como o coronavírus infecta as células – e por que a variante Delta é tão perigosa.

2 Ago, 2021 | 19:07h

How the coronavirus infects cells — and why Delta is so dangerous – Nature

Reforços das vacinas contra COVID nos países ricos geram indignação.

2 Ago, 2021 | 19:06h

COVID boosters for wealthy nations spark outrage – Nature

Conteúdo relacionado: MSF: No COVID-19 booster shots anywhere before healthcare workers and vulnerable people everywhere have access – Médecins Sans Frontières/Doctors Without Borders

Cientistas discutem a questão do reforço da vacina contra COVID-19.

2 Ago, 2021 | 19:04h

Scientists Grapple With Question of COVID-19 Vaccine Booster, as Some Countries Push Ahead – Health Policy Watch

Diretriz Científica AHA | Doença arterial periférica em membro inferior: epidemiologia, tratamento e direções futuras.

2 Ago, 2021 | 19:02h

Lower Extremity Peripheral Artery Disease: Contemporary Epidemiology, Management Gaps, and Future Directions: A Scientific Statement From the American Heart Association – Circulation

Itens principais a saber: Lower Extremity Peripheral Artery Disease: Contemporary Epidemiology, Management Gaps, and Future Directions – American Heart Association

Comentário: The Need for Improved Identification and Treatment of Peripheral Arterial Disease – American Heart Association

Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.